Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	2,697	5,049	5,387	3,516	5,245	740
Market Cap Growth	-16.38%	-6.27%	53.22%	-32.97%	608.78%	540.58%
Enterprise Value	2,409	4,955	5,305	3,491	5,213	643
Last Close Price	52.97	99.19	106.07	70.23	104.76	14.78
PE Ratio	10.56	-	11.72	7.38	13.75	12.12
PS Ratio	0.98	2.09	1.60	1.26	2.27	1.62
PB Ratio	1.25	2.51	2.95	3.11	8.07	2.67
P/TBV Ratio	1.42	2.88	3.42	3.91	8.23	2.67
P/FCF Ratio	-	120.99	-	12.20	-	-
P/OCF Ratio	-	103.77	88.67	10.30	169193.55	-
EV/Sales Ratio	0.87	2.05	1.58	1.25	2.25	1.41
EV/EBITDA Ratio	6.30	10.64	9.38	6.95	12.24	7.80
EV/EBIT Ratio	6.68	11.10	9.68	7.02	12.33	7.81
EV/FCF Ratio	-	118.73	-	12.11	-	-
Debt / Equity Ratio	0.15	0.10	0.07	0.03	0.06	-
Debt / EBITDA Ratio	0.84	0.42	0.24	0.07	0.09	-
Debt / FCF Ratio	-	4.65	-	0.13	-	-
Asset Turnover	-	0.97	1.62	2.02	3.41	2.17
Inventory Turnover	-	1.38	2.03	3.53	23.92	-
Quick Ratio	-	2.21	1.54	0.58	2.28	4.10
Current Ratio	-	3.88	3.64	2.23	2.70	4.24
Return on Equity (ROE)	-	-1.24%	31.05%	53.51%	82.26%	39.04%
Return on Assets (ROA)	-	11.21%	16.46%	22.51%	38.97%	24.46%
Return on Capital (ROIC)	10.67%	13.38%	21.89%	33.52%	54.85%	32.92%
Return on Capital Employed (ROCE)	-	21.90%	29.40%	43.90%	65.10%	29.70%
Earnings Yield	10.15%	-0.47%	8.53%	13.55%	7.27%	8.25%
FCF Yield	-	0.83%	-1.30%	8.20%	-0.24%	-19.21%
Dividend Yield	-	-	-	0.14%	-	-
Payout Ratio	-	-	1.08%	-	-	-
Buyback Yield / Dilution	-7.02%	-1.69%	-1.23%	-	-32.96%	-147.40%
Total Shareholder Return	-7.02%	-1.69%	-1.23%	0.14%	-32.96%	-147.40%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.